Phase-III trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide for primary breast cancer

被引：0
|
作者：
Mross, Klaus
机构：
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2006年 / 182卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：253 / 254
页数：2
相关论文
共 50 条
  • [1] A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer
    Lee, Keun Seok
    Ro, Jungsil
    Nam, Byung-Ho
    Lee, Eun Sook
    Kwon, Youngmee
    Kwon, Hye Soo
    Chung, Ki Wook
    Kang, Han Sung
    Kim, Eun A.
    Kim, Seok Won
    Shin, Kyung Hwan
    Kim, Seok-Ki
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (03) : 481 - 489
  • [2] A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer
    Keun Seok Lee
    Jungsil Ro
    Byung-Ho Nam
    Eun Sook Lee
    Youngmee Kwon
    Hye Soo Kwon
    Ki Wook Chung
    Han Sung Kang
    Eun A Kim
    Seok Won Kim
    Kyung Hwan Shin
    Seok-Ki Kim
    [J]. Breast Cancer Research and Treatment, 2008, 109 : 481 - 489
  • [3] A phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer:: results of the ERASME 3 study
    Cassier, Philippe A.
    Chabaud, Sylvie
    Trillet-Lenoir, Veronique
    Peaud, Pierre-Yves
    Tigaud, Jean-Dominique
    Cure, Herve
    Orfeuvre, Hubert
    Salles, Bruno
    Martin, Claude
    Jacquin, Jean-Philippe
    Agostini, Cecile
    Guastalla, Jean-Paul
    Perol, David
    Bachelot, Thomas
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (02) : 343 - 350
  • [4] A phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer: results of the ERASME 3 study
    Philippe A. Cassier
    Sylvie Chabaud
    Véronique Trillet-Lenoir
    Pierre-Yves Peaud
    Jean-Dominique Tigaud
    Hervé Cure
    Hubert Orfeuvre
    Bruno Salles
    Claude Martin
    Jean-Philippe Jacquin
    Cecile Agostini
    Jean-Paul Guastalla
    David Pérol
    Thomas Bachelot
    [J]. Breast Cancer Research and Treatment, 2008, 109 : 343 - 350
  • [5] Phase III randomised trial of doxorubicin (A) and docetaxel (D) versus A and cyclophosphamide (C) as primary medical therapy (PMT) in women with breast cancer
    Evans, TRJ
    Yellowlees, A
    Foster, E
    Earl, H
    Cameron, DA
    Hutcheon, AW
    Coleman, RE
    Crown, J
    Leonard, RC
    Mansi, JL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 8S - 8S
  • [6] Phase III randomized trial of doxorubicin and docetaxel versus doxorubicin and cyclophosphamide as primary medical therapy in women with breast cancer: An anglo-celtic cooperative oncology group study
    Evans, TRJ
    Yellowlees, A
    Foster, E
    Earl, H
    Cameron, DA
    Hutcheon, AW
    Coleman, RE
    Perren, T
    Gallagher, CJ
    Quigley, M
    Crown, J
    Jones, AL
    Highley, M
    Robert, LMH
    Mansi, JL
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (13) : 2988 - 2995
  • [7] Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer
    Jones, Stephen E.
    Savin, Michael A.
    Holmes, Frankie Ann
    O'Shaughnessy, Joyce A.
    Blum, Joanne L.
    Vukelja, Svetislava
    McIntyre, Kristi J.
    Pippen, John E.
    Bordelon, James H.
    Kirby, Robert
    Sandbach, John
    Hyman, William J.
    Khandelwal, Pankaj
    Negron, Angel G.
    Richards, Donald A.
    Anthony, Stephen P.
    Mennel, Robert G.
    Boehm, Kristi A.
    Meyer, Walter G.
    Asmar, Lina
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (34) : 5381 - 5387
  • [8] TREATMENT OF RECURRENT OR ADVANCED UTERINE SARCOMA - A RANDOMIZED TRIAL OF DOXORUBICIN VERSUS DOXORUBICIN AND CYCLOPHOSPHAMIDE (A PHASE-III TRIAL OF THE GYNECOLOGIC ONCOLOGY GROUP)
    MUSS, HB
    BUNDY, B
    DISAIA, PJ
    HOMESLEY, HD
    FOWLER, WC
    CREASMAN, W
    YORDAN, E
    [J]. CANCER, 1985, 55 (08) : 1648 - 1653
  • [9] Results of clinical endpoints of a randomized phase It trial with doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as primary systemic therapy for early breast cancer
    Schneeweiss, A.
    Ruiz, A.
    Rovira, P.
    Bottini, A.
    Manikhas, A.
    Wacker, J.
    Schumacher, T.
    Wolf, M.
    Segui, M.
    Sinn, P.
    Kennedy, L.
    Mansouri, K.
    Bauknecht, T.
    [J]. BREAST, 2009, 18 : S63 - S63
  • [10] A randomized phase II trial of doxorubicin plus pemetrexed followed by docetaxel versus doxorubicin plus cyclophosphamide followed by docetaxel as neoadjuvant treatment of early breast cancer
    Schneeweiss, A.
    Marme, F.
    Ruiz, A.
    Manikhas, A. G.
    Bottini, A.
    Wolf, M.
    Sinn, H. -P.
    Mansouri, K.
    Kennedy, L.
    Bauknecht, T.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 (03) : 609 - 617
12345